Compare VYGR & IPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VYGR | IPST |
|---|---|---|
| Founded | 2013 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.0M | 163.4M |
| IPO Year | 2015 | N/A |
| Metric | VYGR | IPST |
|---|---|---|
| Price | $3.92 | $0.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $17.00 | $8.20 |
| AVG Volume (30 Days) | ★ 783.0K | 608.5K |
| Earning Date | 06-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,135,000.00 | N/A |
| Revenue This Year | $54.19 | N/A |
| Revenue Next Year | $20.22 | $123.91 |
| P/E Ratio | ★ N/A | $0.01 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.65 | $0.41 |
| 52 Week High | $5.55 | $15.08 |
| Indicator | VYGR | IPST |
|---|---|---|
| Relative Strength Index (RSI) | 46.21 | 34.70 |
| Support Level | $3.60 | N/A |
| Resistance Level | $4.43 | $0.77 |
| Average True Range (ATR) | 0.33 | 0.12 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 10.90 | 25.54 |
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
Heritage Distilling Holding Co Inc is a craft distiller producing, marketing, and selling a diverse line of award-winning craft spirits, including whiskeys, vodkas, gins, rums, and ready-to-drink canned cocktails. The company sells its products through wholesale distribution, directly to consumers through its owned and operated distilleries and tasting rooms located in Washington and Oregon, and by shipping directly to consumers online, where legal. Currently, it sells products in the Pacific Northwest with limited distribution in other states throughout the U.S.